Answer
LITAK (cladribine) is contraindicated during pregnancy because cladribine causes serious birth defects, with teratogenicity and mutagenicity demonstrated in animal studies and in vitro studies with human cell lines.
Sources for this answer
- LITAK 2mg/ml solution for injectionLIPOMED GmbH · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 6Document updated
Sources checked